{"id":"bp-c2","safety":{"commonSideEffects":[{"rate":"null","effect":"Cough"},{"rate":"null","effect":"Dizziness"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BP-C2 works by inhibiting the angiotensin-converting enzyme (ACE), which is a key component of the renin-angiotensin system. This leads to decreased levels of angiotensin II, a potent vasoconstrictor, resulting in vasodilation and reduced blood pressure.","oneSentence":"BP-C2 is a small molecule that targets the renin-angiotensin system to lower blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:57:14.725Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT04186585","phase":"PHASE1","title":"Recommended Dose Estimation of BP-C2","status":"RECRUITING","sponsor":"Meddoc","startDate":"2023-04-01","conditions":"Prostate Cancer","enrollment":8},{"nctId":"NCT03627390","phase":"PHASE2","title":"BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer","status":"COMPLETED","sponsor":"Meabco A/S","startDate":"2014-12-19","conditions":"Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ammonium molybdate complexed with a lignin-derived polymer containing benzene polycarboxylic acids","molybdenum salts of benzene-polycarboxylic acids"],"phase":"phase_2","status":"active","brandName":"BP-C2","genericName":"BP-C2","companyName":"Meddoc","companyId":"meddoc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BP-C2 is a small molecule that targets the renin-angiotensin system to lower blood pressure. Used for Hypertension.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}